Developing therapeutics to effectively inhibit the MYC oncoprotein would mark a key advance towards cancer patient care as MYC is deregulated in over 50% of human cancers. MYC deregulation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback